TSFM
Basic information
Region (hg38): 12:57782761-57808071
Links
Phenotypes
GenCC
Source:
- fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 (Supportive), mode of inheritance: AR
- Leigh syndrome (Moderate), mode of inheritance: AR
- fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Combined oxidative phosphorylation deficiency 3 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Cardiovascular; Gastrointestinal; Musculoskeletal; Neurologic | 17033963; 21119709; 22499341 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (452 variants)
- Fatal_mitochondrial_disease_due_to_combined_oxidative_phosphorylation_defect_type_3 (109 variants)
- Inborn_genetic_diseases (45 variants)
- not_specified (14 variants)
- TSFM-related_disorder (11 variants)
- See_cases (2 variants)
- Encephalomyopathy_with_respiratory_failure_and_lactic_acidosis (2 variants)
- Primary_dilated_cardiomyopathy (1 variants)
- Combined_oxidative_phosphorylation_deficiency (1 variants)
- Nephrotic_syndrome,_type_21 (1 variants)
- Skeletal_myopathy (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TSFM gene is commonly pathogenic or not. These statistics are base on transcript: NM_000005726.6. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 166 | 172 | ||||
| missense | 142 | 160 | ||||
| nonsense | 13 | 22 | ||||
| start loss | 3 | 3 | 6 | |||
| frameshift | 18 | 20 | 39 | |||
| splice donor/acceptor (+/-2bp) | 11 | 11 | ||||
| Total | 27 | 55 | 152 | 174 | 2 |
Highest pathogenic variant AF is 0.0006877717
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| TSFM | protein_coding | protein_coding | ENST00000323833 | 7 | 25483 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 1.92e-9 | 0.132 | 125214 | 0 | 394 | 125608 | 0.00157 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -0.217 | 177 | 169 | 1.05 | 0.00000829 | 2167 |
| Missense in Polyphen | 59 | 63.488 | 0.92931 | 787 | ||
| Synonymous | -0.518 | 77 | 71.4 | 1.08 | 0.00000368 | 712 |
| Loss of Function | 0.247 | 14 | 15.0 | 0.931 | 7.26e-7 | 198 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000643 | 0.000639 |
| Ashkenazi Jewish | 0.000200 | 0.000199 |
| East Asian | 0.000164 | 0.000163 |
| Finnish | 0.0145 | 0.0138 |
| European (Non-Finnish) | 0.000643 | 0.000599 |
| Middle Eastern | 0.000164 | 0.000163 |
| South Asian | 0.00 | 0.00 |
| Other | 0.00124 | 0.00114 |
dbNSFP
Source:
- Function
- FUNCTION: Associates with the EF-Tu.GDP complex and induces the exchange of GDP to GTP. It remains bound to the aminoacyl-tRNA.EF- Tu.GTP complex up to the GTP hydrolysis stage on the ribosome. {ECO:0000255|HAMAP-Rule:MF_03135, ECO:0000269|PubMed:27677415}.;
- Pathway
- Translation;Metabolism of proteins;Mitochondrial translation elongation;Mitochondrial translation
(Consensus)
Recessive Scores
- pRec
- 0.199
Intolerance Scores
- loftool
- 0.376
- rvis_EVS
- -0.03
- rvis_percentile_EVS
- 51.92
Haploinsufficiency Scores
- pHI
- 0.175
- hipred
- N
- hipred_score
- 0.394
- ghis
- 0.533
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.513
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tsfm
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); pigmentation phenotype; vision/eye phenotype;
Gene ontology
- Biological process
- translational elongation;regulation of DNA-templated transcription, elongation;mitochondrial translational elongation;regulation of mitochondrial translation
- Cellular component
- nucleus;mitochondrion;mitochondrial matrix
- Molecular function
- RNA binding;translation elongation factor activity;protein binding